The maker of a diabetes-focused digital health app has published new data showing its product can lead to clinically meaningful improvement in HbA1c for people with severe diabetes. Earlier this summer, Dario Health Corp. released new data showing that its diabetes management tool led to improvement in HbA1c that was significantly greater than the improvement in a cohort of patients who did not use the product.
Read more here.
